Characterization of 18F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves

Circulation: Cardiovascular Imaging

Volumn 10, Issue 3, 2017, Pages

  Mathieu, Cédric ^a   Mikaïl, Nidaa ^a,b,c   Benali, Khadija ^a,b,c   Iung, Bernard ^a,b,c   Duval, Xavier ^a,b,d   Nataf, Patrick ^a,b,c   Jondeau, Guillaume ^a,b,c   Hyafil, Fabien ^a,b,c   Le Guludec, Dominique ^a,b,c   Rouzet, François ^a,b,c  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

18F FDG; infective endocarditis; PET CT; prosthetic heart valve; vasculitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; VASCULITIS; DEVICES; DIAGNOSTIC IMAGING; FACTUAL DATABASE; HEART VALVE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SURGERY; TISSUE DISTRIBUTION; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 85016211029     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.116.005585     Document Type: Article

References (24)

1. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl JMed. 1996;335:407-416. doi: 10.1056/NEJM199608083350607.
2. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med.2013;368:1425-1433. doi: 10.1056/NEJMcp1206782.
3. Anguera I, Miro JM, San Roman JA, de Alarcon A, Anguita M, AlmiranteB, Evangelista A, Cabell CH, Vilacosta I, Ripoll T, Munõz P, Navas E, Gonzalez-Juanatey C, Sarria C, Garcia-Bolao I, Farinãs MC, Rufi G, Miralles F, Pare C, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR, del Rió A, Corey GR; Aorto-Cavitary Fistula in Endocarditis WorkingGroup. Periannular complications in infective endocarditis involving prostheticaortic valves. Am J Cardiol. 2006;98:1261-1268. doi: 10.1016/j.amjcard.2006.05.066.
4. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, AlmiranteB, Munõz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; InternationalCollaboration on Endocarditis-Prospective Cohort Study Investigators.Contemporary clinical profile and outcome of prosthetic valve endocarditis.JAMA. 2007;297:1354-1361. doi: 10.1001/jama.297.12.1354.
5. Chirouze C, Alla F, Fowler VG Jr, Sexton DJ, Corey GR, Chu VH, WangA, Erpelding ML, Durante-Mangoni E, Fernández-Hidalgo N, GiannitsiotiE, Hannan MM, Lejko-Zupanc T, Miró JM, Munõz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B; ICE Prospective Investigators. Impactof early valve surgery on outcome of Staphylococcus aureus prostheticvalve infective endocarditis: analysis in the International Collaborationof Endocarditis-Prospective Cohort Study. Clin Infect Dis. 2015;60:741-749. doi: 10.1093/cid/ciu871.
6. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approachand therapeutic options. Prog Cardiovasc Dis. 2008;50:274-281.doi: 10.1016/j.pcad.2007.10.007.
7. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, BashoreT, Corey GR. Proposed modifications to the Duke criteria for the diagnosisof infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi:10.1086/313753.
8. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: the value of transesophagealechocardiography and outcome: a 5-year study. Am Heart J.2007;154:923-928. doi: 10.1016/j.ahj.2007.06.028.
9. Bonfiglioli R, Nanni C, Morigi JJ, Graziosi M, Trapani F, Bartoletti M, Tumietto F, Ambrosini V, Ferretti A, Rubello D, Rapezzi C, Viale PL, Fanti S. 1F-FDG PET/CT diagnosis of unexpected extracardiac septic embolismsin patients with suspected cardiac endocarditis. Eur J Nucl MedMol Imaging. 2013;40:1190-1196. doi: 10.1007/s00259-013-2426-7.
10. Kestler M, Munõz P, Rodríguez-Creíxems M, Rotger A, Jimenez-RequenaF, Mari A, Orcajo J, Hernández L, Alonso JC, Bouza E; Group for theManagement of Infectious Endocarditis (GAME). Role of (18)F-FDGPET in patients with infectious endocarditis. J Nucl Med. 2014;55:1093-1098. doi: 10.2967/jnumed.113.134981.
11. Mikail N, Benali K, Ou P, Slama J, Hyafil F, Le Guludec D, Rouzet F.Detection of mycotic aneurysms of lower limbs by whole-body (18)F-FDG-PET. JACC Cardiovasc Imaging. 2015;8:859-862. doi: 10.1016/j.jcmg.2014.10.019.
12. Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, CuijpersML, Adang EM, Wanten GJ, Kullberg BJ, Oyen WJ. 18F-FDG PET/CTfor detection of metastatic infection in gram-positive bacteremia. J NuclMed. 2010;51:1234-1240. doi: 10.2967/jnumed.109.072371.
13. Asmar A, Ozcan C, Diederichsen AC, Thomassen A, Gill S. Clinical impactof 18F-FDG-PET/CT in the extra cardiac work-up of patients withinfective endocarditis. Eur Heart J Cardiovasc Imaging. 2014;15:1013-1019. doi: 10.1093/ehjci/jeu054.
14. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, CasaltaJP, Gouriet F, Riberi A, Avierinos JF, Collart F, Mundler O, Raoult D, ThunyF. Positron emission tomography/computed tomography for diagnosis ofprosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucoseuptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374-2382.doi: 10.1016/j.jacc.2013.01.092.
15. Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, Iung B, Vahanian A, Le Guludec D, Hyafil F. Respective performance of 18F-FDGPET and radiolabeled leukocyte scintigraphy for the diagnosis of prostheticvalve endocarditis. J Nucl Med. 2014;55:1980-1985. doi: 10.2967/jnumed.114.141895.
16. Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, Oristrell G, Gracia-Sánchez L, González JJ, Rodríguez-Palomares J, Galinañes M, Maisterra-Santos O, Garcia-Dorado D, Castell-Conesa J, Almirante B, Aguadé-Bruix S, TornosP. Improving the Diagnosis of infective endocarditis in prosthetic valvesand intracardiac devices with 18F-fluordeoxyglucose positron emissiontomography/computed tomography angiography: initial results at an infectiveendocarditis referral center. Circulation. 2015;132:1113-1126.doi: 10.1161/CIRCULATIONAHA.115.015316.
17. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del ZottiF, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, ThunyF, Tornos Mas P, Vilacosta I, Zamorano JL, Erol Ç, NihoyannopoulosP, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, HalvorsenS, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, MestresCA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, TamargoJ, Walker DM; Document Reviewers. 2015 ESC Guidelines for the managementof infective endocarditis: The Task Force for the Managementof Infective Endocarditis of the European Society of Cardiology (ESC).Endorsed by: European Association for Cardio-Thoracic Surgery(EACTS), the European Association of Nuclear Medicine (EANM). EurHeart J. 2015;36:3075-3128. doi: 10.1093/eurheartj/ehv319.
18. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, RybakMJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA; AmericanHeart Association Committee on Rheumatic Fever, Endocarditis, Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgeryand Anesthesia, Stroke Council. Infective Endocarditis in Adults:Diagnosis, Antimicrobial Therapy, Management of Complications:A Scientific Statement for Healthcare Professionals From the AmericanHeart Association. Circulation. 2015;132:1435-1486. doi: 10.1161/CIR.0000000000000296.
19. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correctionfor positron emission tomography/computed tomography scanners. SeminNucl Med. 2003;33:166-179. doi: 10.1053/snuc.2003.127307.
20. DiFilippo FP, Brunken RC. Do implanted pacemaker leads and ICDleads cause metal-related artifact in cardiac PET/CT J Nucl Med.2005;46:436-443.
21. Ghafarian P, Aghamiri SM, Ay MR, Rahmim A, Schindler TH, Ratib O, Zaidi H. Is metal artefact reduction mandatory in cardiac PET/CT imagingin the presence of pacemaker and implantable cardioverter defibrillatorleads Eur J Nucl Med Mol Imaging. 2011;38:252-262. doi: 10.1007/s00259-010-1635-6.
22. Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves: modesof failure. Histopathology. 2009;55:135-144. doi: 10.1111/j.1365-2559.2008.03190.x.
23. Vitale N, Renzulli A, Agozzino L, Pollice A, Tedesco N, de LucaTupputi Schinosa L, Cotrufo M. Obstruction of mechanical mitralprostheses: analysis of pathologic findings. Ann Thorac Surg.1997;63:1101-1106.
24. Keidar Z, Pirmisashvili N, Leiderman M, Nitecki S, Israel O. 18F-FDGuptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med. 2014;55:392-395. doi: 10.2967/jnumed.113.128173